Latest Brain Cancer News

Page 2 of 2

Noxopharm Secures New MTAs and Boosts Cash with $2.34M R&D Rebate

Noxopharm’s December 2024 quarterly report reveals expanding global interest in its Sofra technology through new Material Transfer Agreements and a strengthened cash position following a significant R&D tax rebate.

Ada Torres

29 Jan 2025

Top